# 🧬 CGT 每日情报 (Daily Brief)
> **日期**: 2026-01-21 | **更新时间**: 09:10 (北京时间)
> **监控范围**: Global (In vivo/FDA) & China (NMPA/Biotech)

---

## 🌍 全球前沿 (FDA / In vivo / MNCs)
- `[01:49]` **多发性骨髓瘤的最小残留疾病和完全缓解：用作支持行业加速审批指南的终点**
  <br><small>🇬🇧 *Minimal Residual Disease and Complete Response in Multiple Myeloma: Use as Endpoints to Support Accelerated Approval Guidance for Industry* [🔗Source](https://news.google.com/rss/articles/CBMiU0FVX3lxTE9tRHJPdkdDT1dEUmF4cDVrRXZaWHA3VS1HUWZfRWx2QmduOTFkSmRLcGFwZjI0ei1iWGJGRnNZWTBheXRzWmpQbS1jZ0NmSG0xLTJv?oc=5)</small>
- `[21:00]` **🏛️监管 | Lantern Pharma 的 LP-284 获得 FDA 治疗软组织肉瘤的孤儿药称号**
  <br><small>🇬🇧 *Lantern Pharma's LP-284 Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas* [🔗Source](https://news.google.com/rss/articles/CBMi2AFBVV95cUxNQllhckVlOG9PM3UxQ1M0WEw4X00xd0ZhU3A0QmMwdlJVZ1BFM0ZYbkdWNUQzelRDUmVaZHJHNHRPS204UjJmUjlCTlQycjgycC1ETVpndzhKb2Y3eWtZZlQzLS1RTV9nZ1pPQnFQOEdBSmh3NzFTb0tBaWVXNVZHcVRVS3JURnd4UnJYckxhMkIwcEZzNEx6aU1CdDJpTTNBUWg3N29IRUhwXzg5ME5PTnl2ZnQzbDdES0ZRSmV3REItUlVJMmpqU1NZb2RrY05mWWgyS3hEM3c?oc=5)</small>
- `[20:00]` **非营利性脐带血委员会成立，旨在加强国家公共脐带血库并推进移植和脐带血衍生细胞疗法的创新**
  <br><small>🇬🇧 *Nonprofit Cord Blood Council Launches to Strengthen National Public Cord Blood Banks and Advance Innovation in Transplant and Cord Blood–derived Cell Therapy* [🔗Source](https://news.google.com/rss/articles/CBMiuAJBVV95cUxQT0V1LTlScnVUS2p6cmo1M216N2h1ekxEQjhBdmhDeEdTSGZfTTk3eTBWUGJiSHVNamVMY18zRHlpWTN5Qmd6SDF2T0dsaGJJVG9PVEhtU3dOQTNOS1VFcVNLRFlZamtuWld1S20wRUQ4dTdwY19ub2tQdGtGNXFTbzRpQ1A2cUZvN0RXTWxPUGE5Q2xqcHNoUEh3WmRBQ2hGLUdhbnZxaGQwOVRldDlNeU52Qm1QNzJ6eUt4TTV2ejVWSThRb3FuSlJYNWJuUXpEVTdFZGtpQnhFYnEzQzdLWS1UbDNQSFZldmF1S1d2NUJ3elROaHRmazllc0dZQkczZVQ0Z2g1RTZ4UWRPRFdNbUMyVGdzVWFiXy1IUHhBa2xQNTZXTzl6dkVFMDJOTUNfNlBoRTZydkM?oc=5)</small>
- `[17:00]` **🏛️监管 | ImmunityBio 与 FDA 就 ANKTIVA 的潜在重新提交路径进行监管讨论**
  <br><small>🇬🇧 *ImmunityBio Advances Regulatory Discussions with FDA on Potential Resubmission Path for ANKTIVA* [🔗Source](https://news.google.com/rss/articles/CBMiowJBVV95cUxPeEtqeWhuRzl2bW0xT282c0E0T3FGOUxnVWdYcnRYTVFVRVh2dE9MZUZ3dHl3RktWSHh2cm5XME93MGU5OWVCVFlTQ3ZTMjB4WlpIX3FNRF9CemQwbkY2RmFJZy15QVBIWkNJRzRBTjVxY1l4U19Jcjd4eFVnYkJQMi1TYVZhbXI2SnVfYjQ4d3lEaE5xQlFiQlNRdVlYRGNWZFRvcjAwbnRzWmxwVTJLZklvd2hHcmhCaVhabWdHY0QtN2V2M0hNTzVpMko1TlgxTzl4QWtHZk9BenFGS3JBSVVJaGU5VS1KV0Q2Qm41YUJJZ21KTGdkck00RDlvaVRkcjdDU1gtNmpmZmE3ZXYxNnJKZmZ3SFdhQm9Za3ZmMFZlOU0?oc=5)</small>

---

## 🇨🇳 中国动态 (NMPA / Domestic Players)
- `[08:23]` **🏛️监管 | 首宁生物临床级MSC培养基成功通过FDA DMF备案！持续助力细胞治疗领域发展！** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTFA3M0hvckkxOEpRLVlpREw5eUFhS25GR00tTDF2WndzVXFMenNTVERkUFVyRnBOYlpLMllDN1FKTW12eFVKdjBaOWJLRmtHQXlvQ2poaUdXUGxjUGpQSko1eGlLdkZVelVaOEFPbHFiWG1IekdUUFh4ZkxOZmxmdw?oc=5)
- `[01:00]` **2026年中国值得关注的六种药物**
  <br><small>🇬🇧 *Six drugs to watch in China for 2026* [🔗Source](https://news.google.com/rss/articles/CBMigwFBVV95cUxOZkloUW9rbFFJNmd4el95eEItejJaaFp2eTd6Sm14VkZYNkNNeU9LVFFLdlZqWURpc20wQjFQQ3h0bkE1LWJwN19nWFZLbVBzaFBtOG4zTERxekYwOERfS2UwYjlheG56c0JDQUdxcmpOdnRsMnhvSU5wbG1NeVRNRWdRSQ?oc=5)</small>
- `[19:54]` **6.3 亿美元！阿斯利康收购新型 CAR-T 中国权益** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE5aclZjbTRINko0V0pGSWhfMkswakY2U0lfR3p1cUpXR0gtU2YxdWN4SnlsS1JvYS1TSUNPaVR2bkhlV0FZRWJPY1FwU095bXk0eFdzMFhON00xMGY0Z0hNazBEaUk2dENOVEZGME9XLVJWNUFVU0FzUEdHNU1vZw?oc=5)
- `[18:15]` **🏛️监管 | 我国自研眼科基因治疗药物获国际认可， 角膜营养不良基因编辑临床试验海外获批** [🔗阅读原文](https://news.google.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?oc=5)
- `[17:31]` **🏛️监管 | 博鳌乐城“2型糖尿病的人脐带间充质干细胞治疗技术”正式获批，价格公布！** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE1CcDFCcDlKdzlMTWNSTHlaUWZYbnNwLUVpWWhjU29vVGJ1RzVKWGp6eTJrMXN3U1g2amxkN3ZFREdDYkhWVkprMHYxZ0RmLTEyclhYc0laSFlOUzdXY0pXTUF0Zk9ySzdRZ3Q2cUhYLWIzVUJIb3JrTjN5bi1idw?oc=5)
- `[14:20]` **武田制药美国裁员；阿斯利康收购GPC3 CAR-T疗法中国剩余权益** [🔗阅读原文](https://news.google.com/rss/articles/CBMiVkFVX3lxTFBZWDFSOThCcm1INmtmX2V3NVVIYkMyYUJ0YnJId0xVcHZXeEY5V0NZczBUNng4cTk2dm1ncDBiaHpBS091cFNNSEQydDgwdF9DWTdzLVRR?oc=5)
- `[14:09]` **CAR-T细胞疗法的非典型与致死性毒性** [🔗阅读原文](https://news.google.com/rss/articles/CBMiVkFVX3lxTE1wbWs5QXdXY2I1LXF2UzVwT080UXFoS2NNSC1VTFdZeDdfakwtZXd0eXh3b2VUZ3RSTWNJeGktUF82NWxVbHZJMENuemx1ZHIzUXNmTkVn?oc=5)
- `[14:09]` **CAR-T和双抗治疗相关CMV感染管理的中国专家共识-MedSci.cn** [🔗阅读原文](https://news.google.com/rss/articles/CBMibkFVX3lxTFBFWnpqUlJxVkxWTi1WY2plcHhZUEhoRWdvQjRFQl9USDdtRmZ3UzBYRnZNemsydi1zR3o1cTdxeUphaGRXTXY4bncxbm56RjkzVmt4WFdqMWdiZTA0ai1mNWNpYnpmQ3p0dW9XeU13?oc=5)
- `[10:41]` **华西乐城-贝来类风湿关节炎干细胞临床研究中心正式揭牌** [🔗阅读原文](https://news.google.com/rss/articles/CBMifkFVX3lxTE9nQzhtUzdpMGpPV0pTenM3Q1UzdDcxcThnYUVrTzNjc2hHSVZzNTkwZ3k1RVZyTDlGMEdKU0RvTFA1aXYzSnY3TEdiNHFmSUhHLU5RbW9ldW9POV83aUpnUUk0cGVWMHNGLXVzbjV6SVY5MUdXbTAxZkNHVEJyZw?oc=5)
